Skip to main content

Toxic Epidermal Necrolysis clinical trials at UC Davis

1 research study open to eligible people

Showing trials for
  • Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis

    “Treatment of toxic epidermal necrolysis/Stevens-Johnson’s Syndrome with topical steroid to characterize the genetic makeup of the disease.”

    open to eligible people ages 7-85

    The primary objectives of this study are to investigate the efficacy and safety of topical steroid ointment (clobetasol 0.05%) for the treatment of the cutaneous manifestations of toxic epidermal necrolysis (TEN).

    Sacramento, California

Last updated: